Promising new compound reduces alcohol dependence in animal studies

Scripps Research scientists have found that LY2444296-;a compound that selectively blocks the kappa opioid receptor (KOP)-;may reduce drinking in cases of alcohol dependence in animal studies.

Reagan-Udall Foundation lays out methods for FDA to combat misinformation

The Reagan-Udall Foundation on Thursday published a wide-ranging report on how the FDA can combat misinformation, marking some progress on one of FDA Commissioner Robert

October 6, 2023

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Targeting two brain tumor-associated proteins-;rather than one-;with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent

March 13, 2024

Medicare director, at JPM conference, gives tips on how to lead the nation’s largest payer

SAN FRANCISCO — Over the last three years that Meena Seshamani has led the Center for Medicare, the service has seen sweeping change — much

January 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.